Clinical Trial: Study of Aspirin in Patients With Vestibular Schwannoma
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas
Brief Summary: This is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patients.
Detailed Summary:
Sponsor: Massachusetts Eye and Ear Infirmary
Current Primary Outcome: Progression Free Survival [ Time Frame: Progression, or around 3.5 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Massachusetts Eye and Ear Infirmary
Dates:
Date Received: March 6, 2017
Date Started: June 2017
Date Completion: February 2022
Last Updated: May 4, 2017
Last Verified: May 2017